Home > Services  > Haematology > Dr Allison Mo

Dr Allison Mo

Learn more about Monash Health’s Haematology team.

Dr Allison Mo

Dr Allison Mo is a haematologist with an interest in transfusion medicine, patient blood management, anaemia, haemostasis and thrombosis. In addition to her clinical work, she is undertaking a PhD aiming to optimise transfusion practices in patients with myelodysplastic syndromes. Dr Mo chairs the Monash Health Patient Blood Management working party. She is also involved in education initiatives with the Australian and New Zealand Society of Blood Transfusion (ANZSBT) and the International Society of Blood Transfusion (ISBT).

Recent publications

Mo A, Wood E, McQuilten Z. Platelet transfusion. Current Opinion in Hematology:10.1097/ September 06, 2024. | DOI: 10.1097/

Gammon R, Mo A. The importance of ABO in platelet refractoriness, an often overlooked option. Br J Haematol. 2024; 204(5): 1602–1604. https://doi.org/10.1111/bjh.19435

Mo A, Wood E, Shortt J, Charlton A, Evers D, Hoeks M, et al. Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes. Transfusion. 2024; 64(2): 236–247. https://doi.org/10.1111/trf.17706

Mo A, Weinkove R, Wood EM, et al. Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey. Eur J Haematol. 2024; 112(4): 621-626. doi:10.1111/ejh.14156

Mo A, Wood E, Shortt J, Hu E, McQuilten Z. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes. Eur J Haematol. 2023; 111(4): 592-600. doi:10.1111/ejh.14049

Mo A, Poynton M, Wood E, Shortt J, Brunskill S, Doree C, Sandercock J, Saadah N, Luk E, Stanworth SJ, McQuilten Z. Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review. Blood Reviews. 2023; https://doi.org/10.1016/j.blre.2023.101114

Mo, A. and Higgins, A.M. (2022), Restrictive transfusion thresholds: Have we left patient-centered outcomes behind?. Transfusion, 62: 1929-1932. https://doi.org/10.1111/trf.17105

Mo A, Stanworth SJ, Shortt J, Wood EM, McQuilten ZK. Red cell transfusions: Is less always best? Transfusion. 2021; 61: 2195–2203. https://doi.org/10.1111/trf.16429

Bielby, L., Moss, R., Mo, A., McQuilten, Z. and Wood, E. (2020), The role of the transfusion practitioner in the management of anaemia. VOXS, 15: 82-90. https://doi.org/10.1111/voxs.12523